N-methylphenylethanolamine (NMPE) is a synthetic compound that has been investigated as a potential therapeutic agent for various conditions, including Parkinson's disease and depression. Its synthesis typically involves the methylation of phenylethanolamine, a naturally occurring compound found in the human body. NMPE is believed to exert its effects by modulating the activity of certain neurotransmitters, particularly dopamine and norepinephrine, in the brain. Its importance lies in its potential to offer alternative therapeutic strategies for conditions currently lacking effective treatments. However, further research is necessary to elucidate its exact mechanisms of action, optimize its therapeutic efficacy, and assess its safety and tolerability in humans. This compound is studied due to its structural similarity to other known psychoactive drugs and its potential to interact with neurotransmitter systems implicated in various neurological and psychiatric disorders.'
2-methylamino-1-phenylethanol: structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Halostachys | genus | [no description available] | Amaranthaceae | A family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 913 |
CHEMBL ID | 1241267 |
CHEBI ID | 16913 |
SCHEMBL ID | 210960 |
MeSH ID | M0088467 |
Synonym |
---|
6589-55-5 |
2-(methylamino)-1-phenylethan-1-ol |
(+-)-halostachine |
(+-)-alpha-((methylamino)methyl)benzenemethanol |
2-(methylamino)-1-phenylethanol |
CHEBI:16913 , |
benzyl alcohol, alpha-((methylamino)methyl)-, dl- |
benzyl alcohol, alpha-((methylamino)methyl)- |
ethanol, 2-(methylamino)-1-phenyl- |
win 5529-2 |
alpha-((methylamino)methyl)benzyl alcohol |
einecs 229-525-5 |
brn 1072841 |
dl-1-phenyl-1-oxy-2-(methylamino)-aethan [german] |
benzenemethanol, alpha-((methylamino)methyl)-, (+-)- |
C03711 |
N-METHYLPHENYLETHANOLAMINE , |
alpha-[(methylamino)methyl]-benzyl alcohol |
68579-60-2 |
alpha-(methylaminomethyl)benzyl alcohol, 99% |
alpha-(methylaminomethyl)benzyl alcohol |
alpha-[(methylamino)methyl]benzyl alcohol |
BMSE000396 |
2-methylamino-1-phenylethanol |
CHEMBL1241267 |
AKOS005207037 |
dl-1-phenyl-1-oxy-2-(methylamino)-aethan |
4-13-00-01802 (beilstein handbook reference) |
unii-u7b63fx8ch |
u7b63fx8ch , |
FT-0625424 |
FT-0625425 |
BRD-A79058669-001-01-1 |
SCHEMBL210960 |
2-methylamino-1-phenyl-ethanol |
alpha-[(methylamino)methyl]benzenemethanol |
(2-hydroxy-2-phenylethyl)methylamine |
alpha-(methylaminomethyl)-benzyl alcohol |
TS-02000 |
benzenemethanol, .alpha.-[(methylamino)methyl]- |
.alpha.-((methylamino)methyl)benzyl alcohol |
benzyl alcohol, .alpha.-((methylamino)methyl)- |
.alpha.-(methylaminomethyl)benzyl alcohol |
dl-halostachine |
n-methyl-.beta.-hydroxylphenylethylamine |
1-phenyl-2-(n-methylamino)ethanol |
halostachine, (+/-)- |
methyl(2-hydroxy-2-phenylethyl)amine |
(+/-)-halostachine |
benzenemethanol, .alpha.-((methylamino)methyl)- |
dl-alpha-(methylaminomethyl)benzylalcohol |
mfcd00004506 |
dl-alpha-(methylaminomethyl)benzyl alcohol |
alpha-((methylamino)methyl)-dl-benzyl alcohol |
BCP22653 |
CS-0204443 |
|a-(methylaminomethyl)benzyl alcohol |
DTXSID90988242 |
Q27102132 |
SB38173 |
a-(methylaminomethyl)benzyl alcohol |
A867016 |
EN300-1251177 |
alpha -(methylaminomethyl)benzyl alcohol |
SY078893 |
Role | Description |
---|---|
human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
phenylethanolamines | An ethanolamine compound having a phenyl (substituted or unsubstituted) group on the carbon bearing the hydroxy substituent. |
alkaloid | Any of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID513146 | Binding affinity to human beta-2 adrenergic receptor delta 5-C271 mutant expressed in Spodoptera frugiperda Sf9 cells | 2006 | Nature chemical biology, Aug, Volume: 2, Issue:8 | Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. |
AID513152 | Partial agonist activity at human biamane labelled beta-2 adrenergic receptor delta 5-C271/Trp135 mutant assessed as bimane response by fluorescence spectroscopy | 2006 | Nature chemical biology, Aug, Volume: 2, Issue:8 | Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. |
AID513154 | Binding affinity to human beta-2 adrenergic receptor delta 5-C271/W135 mutant expressed in Spodoptera frugiperda Sf9 cells | 2006 | Nature chemical biology, Aug, Volume: 2, Issue:8 | Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.01) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |